鄭慧文、余萬能 中華民國藥事品質改革協會

本計畫目的為促進產業發展，維護民眾中藥使用安全，檢討分析全民健康保險對於濃縮中藥給付藥費及藥事服務費之合理性，成立專家規劃小組，調查分析全民健康保險支付制度有關中西醫門診藥費及藥事服務費給付規定之差異，就法規面探討中醫門診法定調劑人員之立法背景，以及參與調劑之比例及經濟面原因，實際調查分析中醫醫療機構門診處方箋使用濃縮中藥之製劑數目及處方日數，使用濃縮中藥之品項數採購價格，專業調劑中藥之合理時間及合理調劑量，中藥廠濃縮中藥之製造銷售成本，推估藥事服務費及藥費之合理成本，並由處方調劑專業人員之獲得性，及藥事法管理之法制性，研議藥品製造供應及藥事服務之合理成本，規劃濃縮中藥合理健保給付藥費及藥事服務費之政策方案，與產官學座談研討規劃合理給付方案，提供中醫藥委員會政策參考。

關鍵字：濃縮中藥、全民健保、藥費、藥事服務費、日劑量、成本分析

Study on Developing Resonable Payments of Concentrated Chinese Medicine for National Health Insurance

Hui-wen Cheng and Wan-nan Yu Quality Improvement for Pharmaceutical Affairs Association, Taiwan

The purpose of this project is to promote industrial development, maintain the safety for the Chinese medicine usage, and review if the payments of concentrated Chinese medicine and pharmaceutical service from National Health Insurance are reasonable. Survey and analysis on the payment system of National Health Insurance will be conducted, and the legislative background of the statutory dispenser of Chinese medicine will also be discussed through an effective regulatory advisory system. And an optimal cost of pharmaceutical service will be evaluated through the analysis on preparation quantities, purchasing prices, dispensing time and workloads, production cost of the pharmaceutical companies in accordance with availability of professionals, the legal system of pharmaceutical affairs. A policy on reasonable payment will be discussed in workshops with industrial, governmental and academic experts and will then be made recommendations to CCMP.